SCHEMBL2805508

SCHEMBL2805508

N#Cc1ccc(S(=O)(=O)Nc2ccc(C3Cc4cnc(NCCCN5CCCC5)nc4-c4ccccc43)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.41
AR P10275 1/20 0.38
SRC P12931 3/20 0.37
FGFR2 P21802 1/20 0.36
KDM1A O60341 1/20 0.36
MAOA P21397 1/20 0.36
MAPT P10636 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
CYP19A1 P11511 1/20 0.35
DRD2 P14416 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
DRD3 P35462 1/20 0.34
HTR6 P50406 1/20 0.34
MEN1 O00255 1/20 0.34
MALT1 Q9UDY8 1/20 0.34
HSD11B1 P28845 1/20 0.34
CDK1 P06493 1/20 0.34
KDR P35968 1/20 0.34
MLNR O43193 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2802057 0.92 FGFR1 (0.48) FGFR1SRCFGFR2MALT1
SCHEMBL2804068 0.91 FGFR1 (0.43) FGFR1ARSRCFGFR2MALT1
SCHEMBL2807328 0.91 FGFR1 (0.43) FGFR1ARSRCFGFR2MAPT
SCHEMBL2802673 0.89 FGFR1 (0.43) FGFR1FGFR2MAPTHRH3MEN1
SCHEMBL2802886 0.88 FGFR1 (0.43) FGFR1SRCFGFR2MAPTMEN1
SCHEMBL2804168 0.87 FGFR1 (0.47) FGFR1SRCFGFR2
SCHEMBL2802257 0.86 FGFR1 (0.43) FGFR1SRCFGFR2MALT1MERTK
SCHEMBL2802095 0.85 FGFR1 (0.40) FGFR1SRCFGFR2HRH3MALT1
SCHEMBL2804086 0.85 HTR6 (0.43) FGFR1FGFR2DRD2HTR2AHTR6
SCHEMBL2802698 0.84 FGFR1 (0.38) FGFR1SRCFGFR2MALT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 FGFR1 530/4885AR 960/4885SRC 642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.